Siren Biotechnology
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. No cookies to display. No cookies to display. No cookies to display. No cookies to display. At Siren, we are combining the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single, powerful new treatment modality to fight cancer. Brain Cancer: An Ideal Initial Setting Brain tumors are our first stop en route to re-inventing solid tumor cancer therapy overall. These are devastating diseases with limited treatment options. Our AAV immuno-gene therapy is designed to overcome key challenges that have caused past therapies to fail. We are completely reimagining how to treat these cancers. We have the scientific expertise, motivation, and passion to tackle key challenges, solve big problems, and deliver on the massive potential of AAV immuno-gene therapy for patien
Explore this link on the map →